Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization

Código QR

Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization

Chiba et al. describe the use of MS2 bacteriophage coat proteins to develop nanocarriers that display the SARS-CoV-2 spike proteins multivalently for vaccine applications. The vaccine elicited high neutralizing antibody titers and protected Syrian hamsters from virus infection after a single immuniz...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shiho Chiba, Steven J. Frey, Peter J. Halfmann, Makoto Kuroda, Tadashi Maemura, Jie E. Yang, Elizabeth R. Wright, Yoshihiro Kawaoka, Ravi S. Kane
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/eccc0e36630d4307b1d6da12b00abf09
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
por: Tadashi Maemura, et al.
Publicado: (2021)

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.
por: Katarina M Braun, et al.
Publicado: (2021)

An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
por: Yan Guo, et al.
Publicado: (2021)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Yuko Sakai-Tagawa, et al.
Publicado: (2021)

Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
por: Rebecca L. Brocato, et al.
Publicado: (2021)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Edurne Rujas, et al.
Publicado: (2021)

Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease
por: Bryce M. Warner, et al.
Publicado: (2021)

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.
por: Rakesh Kulkarni, et al.
Publicado: (2021)

Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection
por: Marion Ferren, et al.
Publicado: (2021)

Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection
por: Stuart Dowall, et al.
Publicado: (2021)

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Jean-Sélim Driouich, et al.
Publicado: (2021)

A multivalent T-antigen-based vaccine for Group A Streptococcus
por: Jacelyn M. S. Loh, et al.
Publicado: (2021)

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
por: Phanramphoei N. Frantz, et al.
Publicado: (2021)

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
por: Tingting Li, et al.
Publicado: (2021)

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
por: Chia-En Lien, et al.
Publicado: (2021)

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
por: Clement A. Meseda, et al.
Publicado: (2021)

Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2
por: Yang SJ, et al.
Publicado: (2021)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Kyle Rosenke, et al.
Publicado: (2021)

Structure-based design of chimeric antigens for multivalent protein vaccines
por: S. Hollingshead, et al.
Publicado: (2018)

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters
por: Qingmei Jia, et al.
Publicado: (2021)

SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters
por: Julia R. Port, et al.
Publicado: (2021)

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
por: Robbert Boudewijns, et al.
Publicado: (2020)

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
por: Delphine C. Malherbe, et al.
Publicado: (2021)

Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease
por: Joan E. M. van der Lubbe, et al.
Publicado: (2021)

Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency
por: Martin JT, et al.
Publicado: (2018)

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
por: Jiandong Huo, et al.
Publicado: (2021)

Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters
por: Bobo Wing-Yee Mok, et al.
Publicado: (2021)

Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
por: Laura Fernández, et al.
Publicado: (2021)

Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model
por: Santosh Dhakal, et al.
Publicado: (2021)

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2
por: Hiroshi Ueki, et al.
Publicado: (2020)

Racing for a SARS‐CoV‐2 vaccine
por: Özlem Türeci, et al.
Publicado: (2021)

Multivalent engagement of TFIID to nucleosomes.
por: Rick van Nuland, et al.
Publicado: (2013)

Identification of interferon-stimulated genes that attenuate Ebola virus infection
por: Makoto Kuroda, et al.
Publicado: (2020)

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins
por: Adam Leach, et al.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021)

Sweet Syndrome Following SARS-CoV2 Vaccination
por: Maria Efenesia Baffa, et al.
Publicado: (2021)

Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters
por: Wen Su, et al.
Publicado: (2021)

Multivalent nanosystems: targeting monocytes/macrophages
por: Poupot R, et al.
Publicado: (2018)

Imaging the polymerization of multivalent nanoparticles in solution
por: Juyeong Kim, et al.
Publicado: (2017)

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Marloes Grobben, et al.
Publicado: (2021)